Clinical characteristics of Korean lung cancer patients with programmed death-ligand 1 expression

被引:0
|
作者
Park, H-Y. [1 ]
机构
[1] Chonnam Natl Univ, Hwasun Hosp, Pulm Internal Med, Hwasun, South Korea
关键词
D O I
10.1016/S1556-0864(18)30325-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
48P
引用
收藏
页码:S25 / S25
页数:1
相关论文
共 50 条
  • [1] Clinical Characteristics of Korean Lung Cancer Patients with Programmed Death-Ligand 1 Expression
    Oh, I.
    Park, H.
    Park, C.
    Kim, Y.
    Song, S.
    Kim, S.
    Choi, Y. D.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S896 - S897
  • [2] Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression
    Park, Ha-Young
    Oh, In-Jae
    Kho, Bo Gun
    Kim, Tae-Ok
    Shin, Hong-Joon
    Park, Cheol Kyu
    Kwon, Yong-Soo
    Kim, Yu-Il
    Lim, Sung-Chul
    Kim, Young-Chul
    Choi, Yoo-Duk
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2019, 82 (03) : 227 - 233
  • [3] Heterogeneity of programmed death-ligand 1 expression in multifocal lung cancer
    Mansfield, A. S.
    Murphy, S.
    Peikert, T.
    Yi, J.
    Vasmatzis, G.
    Wigle, D.
    Aubry, M. C.
    LUNG CANCER, 2016, 91 : S25 - S26
  • [4] Heterogeneity of programmed cell death-ligand 1 expression in lung cancer
    Mansfield, Aaron
    Murphy, Stephen
    Peikert, Tobias
    Vasmatzis, George
    Wigle, Dennis
    Aubry, Marie Christine
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S31 - S32
  • [5] Programmed death-ligand 1 expression in rectal cancer
    Jomrich, G.
    Silberhumer, G. R.
    Marian, B.
    Beer, A.
    Muellauer, L.
    EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA, 2016, 48 (06): : 352 - 356
  • [6] Programmed death-ligand 1 expression in rectal cancer
    G. Jomrich
    G. R. Silberhumer
    B. Marian
    A. Beer
    L. Müllauer
    European Surgery, 2016, 48 : 352 - 356
  • [7] The expression of programmed death-ligand 1 in patients with invasive breast cancer
    Meng, Yi
    Wu, Hongyan
    Yao, Yongzhong
    Li, Rong
    GLAND SURGERY, 2020, 9 (06) : 2106 - 2115
  • [8] Programmed Death-Ligand 1 Expression in Lymphovascular Tumor Emboli in Lung Cancer
    Yeh, Yi-Chen
    Ma, Hsiu-Hsun
    Chu, Ping-Yuan
    Ho, Hsiang-Ling
    Chou, Teh-Ying
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (07):
  • [9] Programmed Death-Ligand 1 Expression and EGFR Mutations in Multifocal Lung Cancer
    Haratake, Naoki
    Toyokawa, Gouji
    Takada, Kazuki
    Kozuma, Yuka
    Matsubara, Taichi
    Takamori, Shinkichi
    Akamine, Takaki
    Katsura, Masakazu
    Shoji, Fumihiro
    Okamoto, Tatsuro
    Oda, Yoshinao
    Maehara, Yoshihiko
    ANNALS OF THORACIC SURGERY, 2018, 105 (02): : 448 - 454
  • [10] Lung cancer patients with positive programmed death-ligand 1 expression endure graver postoperative pain
    Wang, Lu
    Zhou, Jian
    Liu, Huixin
    Xu, Hao
    Li, Huifang
    Feng, Yi
    Tian, Xue
    EUROPEAN JOURNAL OF PAIN, 2023, 27 (02) : 248 - 256